BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

規制と法律 · 2004/1/141 分で読めます

Clarification of the Exemption of Sales by Retail Distributors of Pseudoephedrine and Phenylpropanolamine Products

ローカル自動翻訳 · 情報源の原言語

概要

By this interpretive rule, DEA is providing guidance to retail distributors for compliance with the law and DEA regulations regarding the exemption of sales of pseudoephedrine or phenylpropanolamine regulated products. Pseudoephedrine and phenylpropanolamine, which are regulated as List I chemicals, are components of many over-the-counter cold and allergy products. This rule does not change DEA's regulations and will have no impact on individual retail customers of such products who have been purchasing them from retailers which have been properly following DEA's regulations. DEA regulations already provide--and this rule clarifies--that an exemption from being a regulated transaction exists for sales of ordinary over-the-counter pseudoephedrine and phenylpropanolamine products ("safe harbor" products) by retail distributors. However, some sellers have failed to adequately understand that this exemption must be considered in the context of the definition of a "retail distributor." A retail distributor is one whose sales of regulated pseudoephedrine and phenylpropanolamine products are limited almost exclusively to quantities below the 9 gram threshold--whether these products are de

情報源の原言語: Federal Register — Justice Department原文の発表を開く →

関連インサイト

ビジネスインサイト →